Immunity to carcinogen-induced transplantable fibrosarcoma in B2/B2 chickens. V. Relationship to tumor cell-specific delayed hypersensitivity and serum antibody.

Abstract Lasting immunity to the chemically induced (DMBA) fibrosarcomas (CHCT-NYU1, 2, and 4) of SC chickens ( B2 B2 ) can be obtained by injection of Corynebacterium parvum (CP)-primed chickens with tumor cells and CP in one wing and tumor cells alone in the other wing. The local delayed hypersensitivity (DH) reaction to CP in the wing inhibits local growth completely, whereas the tumor on the contralateral side shows transient growth. In the present studies, the development of tumor immunity was studied in detail by monitoring DH and antibody formation to the tumor cells and adoptive immunity with spleen cells in Winn tests. Injection of NYU1 cells alone in normal or CP-treated animals induced transient immunity in Winn tests in 50% of the animals, weak DH reactivity, and antibody detectable by immunofluorescence within the first 2 weeks. Chickens receiving both NYU1 cells and CP in one wing and NYU1 cells alone on the other side developed stronger DH reactions to the tumor cells and a higher incidence of immunity in Winn tests which was sustained throughout the period of observation. Antibody levels were similar to those of animals receiving tumor cells alone. In contrast, injection of CP and tumor cells on one side without a tumor challenge on the contralateral side did not induce detectable immunity in CP-primed chickens. Chickens immunized to NYU2 and 4 cells were also tested for DH reactivity and antibody formation. Studies on the cross-reactivity between the tumor lines showed that there was cross-reactivity at the humoral level while at the cellular level this was not apparent. However, animals immune to one tumor line rejected transplants of another tumor line. Observations on the antibody specificity(s) suggested that it was not directed against minor histocompatibility or avian sarcoma viral antigens. SC embryo fibroblasts could induce DH, and serum antibody induced by tumor cells usually reacted also with such embryo cells.

[1]  I. Djerassi,et al.  Immunotherapy for accessible tumors utilizing delayed hypersensitivity reactions and separated components of the immune system. , 1976, The Medical clinics of North America.

[2]  M. Palladino,et al.  Chemical carcinogen-induced transplantable fibrosarcomas in histocompatible chickens. I. Incidence of tumor induction in normal and bursectomized chickens. , 1976, Journal of the National Cancer Institute.

[3]  R. W. Baldwin,et al.  Tumour‐related antigen specificities associated with 3‐methylcholanthrene‐treated rat embryo cells , 1979, International journal of cancer.

[4]  R. North,et al.  Mchanisms of antitumor action of Corynebacterium parvum: nonspecific tumor cell destruction at site of immunologically mediated sensitivity reaction to C. parvum. , 1975, Journal of the National Cancer Institute.

[5]  D. Char,et al.  Cutaneous delayed hypersensitivity responses to tumor‐associated and other antigens in acute leukemia , 1973 .

[6]  R. Bomford.  The comparative selectivity of adjuvants for humoral and cell-mediated immunity. II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour antigens in the mouse of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bord , 1980, Clinical and experimental immunology.

[7]  M. Palladino,et al.  Immunity to transplantable carcinogen induced fibrosarcomas in B2/B2 chickens. II. Macrophage dependency of adoptive T cell mediated tumor immunity. , 1978, Cellular immunology.

[8]  R. Witter,et al.  Differential effect of maternal antibodies on efficacy of cellular and cell-free Marek's disease vaccines. , 1979, Avian pathology : journal of the W.V.P.A.

[9]  J. Gamble,et al.  Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression , 1976, The Journal of experimental medicine.

[10]  G. Thorbecke,et al.  T cell tolerance in the chicken. I. Parameters affecting tolerance induction to human gamma-globulin in agammaglobulinemic and normal chickens. , 1978, Journal of immunology.

[11]  N. Anderson,et al.  Cancer, differentiation and embryonic antigens: some central problems. , 1974, Advances in cancer research.

[12]  V. Likhite.  Suppression of the incidence of death with spontaneous tumours in DBA/2 mice after Corynebacterium parvum-mediated rejection of syngeneic tumours , 1976, Nature.

[13]  Youdim,et al.  Cooperation of immune lymphoid and reticuloendothelial cells during Listeria monocytogenes-mediated tumor immunity. , 1977, Cancer research.

[14]  I. Bernstein,et al.  Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin. , 1971, Journal of the National Cancer Institute.

[15]  M. Palladino,et al.  Chemical carcinogen-induced transplantable fibrosarcomas in histocompatible chickens. II. Effect of age and thymectomy on tumor incidence. , 1980, Journal of the National Cancer Institute.

[16]  M. Scott,et al.  Depression of delayed-type hypersensitivity by Corynebacterium parvum: mandatory role of the spleen. , 1974, Cellular immunology.

[17]  J. Rosengren,et al.  Detection of antibodies to embryonic antigens in sera of multiparous or colon tumor‐bearing rats by a new indirect immunofluorescence assay , 1977, International journal of cancer.

[18]  H. von Boehmer,et al.  The separation of different cell classes from lymphoid organs. IX. A simple and rapid method for removal of damaged cells from lymphoid cell suspensions. , 1973, Journal of immunological methods.

[19]  D. Morton,et al.  Immunotherapy experiments with a methylcholanthrene-induced guinea pig liposarcoma. , 1971, Journal of the National Cancer Institute.

[20]  S. Howell,et al.  Defects in cell‐mediated immunity during growth of a syngeneic simian virus‐induced tumor , 1975, International journal of cancer.

[21]  J. Ivanyi,et al.  An immunofluorescent technique for the detection of lymphocyte alloantigens. , 1977, Journal of immunological methods.

[22]  H. Kirchner,et al.  Suppression of cell-mediated tumour immunity by Corynebacterium parvum , 1975, Nature.

[23]  H. Winn,et al.  Immune mechanisms in homotransplantation. II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts. , 1961, Journal of immunology.

[24]  K. Sikora,et al.  Immunoprotection by embryonal carcinoma cells for methyl-cholanthrene-induced murine sarcomas , 1977, Nature.

[25]  R. W. Baldwin,et al.  Influence of immunotherapeutic agents on the progression of spontaneously arising, metastasizing rat mammary adenocarcinomas of varying immunogenicities. , 1978, Cancer research.

[26]  M. Palladino,et al.  Immunity to transplantable carcinogen‐induced fibrosarcomas in B2/B2 chickens. III. Tumor growth inhibition by local delayed hypersensitivity reactions to unrelated antigens , 1978, European journal of immunology.

[27]  D. Cogan,et al.  Cutaneous delayed hypersensitivity reactions to soluble melanoma antigen in patients with ocular malignant melanoma. , 1974, The New England journal of medicine.

[28]  R. Bomford.  The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin , 1980, Clinical and experimental immunology.

[29]  R. Bomford.  An analysis of the factors allowing promotion (rather than inhibition) of tumour growth by corynebacterium parvum , 1977, International journal of cancer.

[30]  E. Shevach,et al.  The Role of Ia Antigens in T Cell Activation , 1977, Immunological reviews.

[31]  M. Palladino,et al.  Immunity to transplantable carcinogen-induced fibrosarcomas in B2/B2 chickens. I. Use of bacterial adjuvants in induction of immunity demonstrable in Winn tests. , 1978, Cellular immunology.

[32]  R. Bomford,et al.  Comparison of the potentiation of specific tumor immunity in mice by Corynebacterium parvum or BCG. , 1976, Journal of the National Cancer Institute.

[33]  S. Pollack.  Expression of oncofetal antigens on murine sarcomas characterized for expression of endogenous MuLV , 1978, International journal of cancer.